[Advanced hepatocellular carcinoma: value of systemic chemotherapy combining adriamycin, amiodarone and 5-fluorouracil].
Bedenne
L
L
Chauffert
B
B
Lorcerie
B
B
Faivre
J
J
Hillon
P
P
Klepping
C
C
Martin
F
F
D000328:Adult; D000368:Aged; D000638:Amiodarone / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D006528:Carcinoma, Hepatocellular / Q000188:drug therapy*; D004317:Doxorubicin / Q000627:therapeutic use; D005260:Female; D005472:Fluorouracil / Q000627:therapeutic use; D006801:Humans; D008113:Liver Neoplasms / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged
D004317:Doxorubicin; D000638:Amiodarone; D005472:Fluorouracil
Carcinomes hépatocellulaires évolués: intérêt d'une chimiothérapie systémique associant adriamycine, amiodarone et 5 fluoro-uracile.